Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 316 articles:
HTML format
Text format



Single Articles


    January 2018
  1. WU PW, Huang CC, Chao WC, Sun CC, et al
    Impact of influenza vaccine on childhood otitis media in Taiwan: A population-based study.
    PLoS One. 2018;13:e0190507.
    PubMed     Text format     Abstract available


  2. TARIGAN S, Wibowo MH, Indriani R, Sumarningsih S, et al
    Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    PLoS One. 2018;13:e0190947.
    PubMed     Text format     Abstract available


  3. CHAO WC, Tseng CH, Chien YC, Sheu CC, et al
    Association of day 4 cumulative fluid balance with mortality in critically ill patients with influenza: A multicenter retrospective cohort study in Taiwan.
    PLoS One. 2018;13:e0190952.
    PubMed     Text format     Abstract available


  4. COWLING BJ, Chui CSL, Lim WW, Wu P, et al
    Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015.
    PLoS One. 2018;13:e0190306.
    PubMed     Text format     Abstract available


  5. HSIA HP, Yang YH, Szeto WC, Nilsson BE, et al
    Amino acid substitutions affecting aspartic acid 605 and valine 606 decrease the interaction strength between the influenza virus RNA polymerase PB2 '627' domain and the viral nucleoprotein.
    PLoS One. 2018;13:e0191226.
    PubMed     Text format     Abstract available


  6. MORE S, Yang X, Zhu Z, Bamunuarachchi G, et al
    Regulation of influenza virus replication by Wnt/beta-catenin signaling.
    PLoS One. 2018;13:e0191010.
    PubMed     Text format     Abstract available


  7. LEE YT, Ko EJ, Lee Y, Kim KH, et al
    Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
    PLoS One. 2018;13:e0190868.
    PubMed     Text format     Abstract available


  8. TEWAWONG N, Marathe BM, Poovorawan Y, Vongpunsawad S, et al
    Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    PLoS One. 2018;13:e0190877.
    PubMed     Text format     Abstract available


  9. KIM H, Kimoto T, Sakai S, Takahashi E, et al
    Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    PLoS One. 2018;13:e0191133.
    PubMed     Text format     Abstract available


  10. WANG QW, Su Y, Sheng JT, Gu LM, et al
    Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-kappaB signal pathways.
    PLoS One. 2018;13:e0191793.
    PubMed     Text format     Abstract available


  11. BELKHIRIA J, Hijmans RJ, Boyce W, Crossley BM, et al
    Identification of high risk areas for avian influenza outbreaks in California using disease distribution models.
    PLoS One. 2018;13:e0190824.
    PubMed     Text format     Abstract available


  12. OPRIESSNIG T, Gauger PC, Gerber PF, Castro AMMG, et al
    Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
    PLoS One. 2018;13:e0191739.
    PubMed     Text format     Abstract available


  13. TUTYKHINA I, Esmagambetov I, Bagaev A, Pichugin A, et al
    Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    PLoS One. 2018;13:e0191574.
    PubMed     Text format     Abstract available


  14. GONZALEZ-PARRA G, De Ridder F, Huntjens D, Roymans D, et al
    A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.
    PLoS One. 2018;13:e0192645.
    PubMed     Text format     Abstract available


  15. SASAKI E, Momose H, Hiradate Y, Furuhata K, et al
    Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.
    PLoS One. 2018;13:e0191896.
    PubMed     Text format     Abstract available


  16. CHEN E, Wang MH, He F, Sun R, et al
    An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China.
    PLoS One. 2018;13:e0193052.
    PubMed     Text format     Abstract available


  17. CASAS-APARICIO GA, Leon-Rodriguez I, Hernandez-Zenteno RJ, Castillejos-Lopez M, et al
    Aggressive fluid accumulation is associated with acute kidney injury and mortality in a cohort of patients with severe pneumonia caused by influenza A H1N1 virus.
    PLoS One. 2018;13:e0192592.
    PubMed     Text format     Abstract available


  18. BASKIN E
    Increasing influenza vaccination rates via low cost messaging interventions.
    PLoS One. 2018;13:e0192594.
    PubMed     Text format     Abstract available


  19. PASCOA R, Rodrigues AP, Silva S, Nunes B, et al
    Comparison between influenza coded primary care consultations and national influenza incidence obtained by the General Practitioners Sentinel Network in Portugal from 2012 to 2017.
    PLoS One. 2018;13:e0192681.
    PubMed     Text format     Abstract available


  20. LEE RU, Won SH, Hansen C, Crum-Cianflone NF, et al
    25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population.
    PLoS One. 2018;13:e0192479.
    PubMed     Text format     Abstract available


  21. MUNYUA P, Onyango C, Mwasi L, Waiboci LW, et al
    Identification and characterization of influenza A viruses in selected domestic animals in Kenya, 2010-2012.
    PLoS One. 2018;13:e0192721.
    PubMed     Text format     Abstract available


  22. BERKHOUT C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, et al
    Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.
    PLoS One. 2018;13:e0192155.
    PubMed     Text format     Abstract available


  23. NEWMAN LP, Bhat N, Fleming JA, Neuzil KM, et al
    Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.
    PLoS One. 2018;13:e0193263.
    PubMed     Text format     Abstract available


  24. KIM AR, Lee DH, Lee SH, Rubino I, et al
    Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    PLoS One. 2018;13:e0191277.
    PubMed     Text format     Abstract available


  25. COLOMBO C, Podlipnik C, Lo Presti L, Niikura M, et al
    Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.
    PLoS One. 2018;13:e0193623.
    PubMed     Text format     Abstract available


  26. ZHENG H, Woodall WH, Carlson AL, DeLisle S, et al
    Can long-term historical data from electronic medical records improve surveillance for epidemics of acute respiratory infections? A systematic evaluation.
    PLoS One. 2018;13:e0191324.
    PubMed     Text format     Abstract available


  27. BASILE L, Oviedo de la Fuente M, Torner N, Martinez A, et al
    Real-time predictive seasonal influenza model in Catalonia, Spain.
    PLoS One. 2018;13:e0193651.
    PubMed     Text format     Abstract available


  28. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    PubMed     Text format     Abstract available


  29. SINGH M, Toribio JA, Scott AB, Groves P, et al
    Assessing the probability of introduction and spread of avian influenza (AI) virus in commercial Australian poultry operations using an expert opinion elicitation.
    PLoS One. 2018;13:e0193730.
    PubMed     Text format     Abstract available


  30. POWERS JH 3RD, Bacci ED, Leidy NK, Poon JL, et al
    Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).
    PLoS One. 2018;13:e0194180.
    PubMed     Text format     Abstract available


  31. CASALINO E, Ghazali A, Bouzid D, Antoniol S, et al
    Patient's behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient's influenza vaccine uptake.
    PLoS One. 2018;13:e0193029.
    PubMed     Text format     Abstract available


  32. KOCH RM, Kox M, van den Kieboom C, Ferwerda G, et al
    Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans.
    PLoS One. 2018;13:e0191937.
    PubMed     Text format     Abstract available


  33. SRIVASTAV A, Santibanez TA, Lu PJ, Stringer MC, et al
    Preventive behaviors adults report using to avoid catching or spreading influenza, United States, 2015-16 influenza season.
    PLoS One. 2018;13:e0195085.
    PubMed     Text format     Abstract available


  34. GENTILE A, Lucion MF, Del Valle Juarez M, Martinez AC, et al
    Influenza virus: 16 years' experience of clinical epidemiologic patterns and associated infection factors in hospitalized children in Argentina.
    PLoS One. 2018;13:e0195135.
    PubMed     Text format     Abstract available


  35. NGUENHA N, Tivane A, Pale M, Machalele L, et al
    Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016.
    PLoS One. 2018;13:e0194138.
    PubMed     Text format     Abstract available


  36. RIBEIRO AF, Pellini ACG, Kitagawa BY, Marques D, et al
    Severe influenza A(H1N1)pdm09 in pregnant women and neonatal outcomes, State of Sao Paulo, Brazil, 2009.
    PLoS One. 2018;13:e0194392.
    PubMed     Text format     Abstract available


  37. JANG H, Elaish M, Kc M, Abundo MC, et al
    Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    PLoS One. 2018;13:e0195285.
    PubMed     Text format     Abstract available


  38. REEVES AB, Hall JS, Poulson RL, Donnelly T, et al
    Influenza A virus recovery, diversity, and intercontinental exchange: A multi-year assessment of wild bird sampling at Izembek National Wildlife Refuge, Alaska.
    PLoS One. 2018;13:e0195327.
    PubMed     Text format     Abstract available


  39. RAJENDRAN M, Sun W, Comella P, Nachbagauer R, et al
    An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    PLoS One. 2018;13:e0194830.
    PubMed     Text format     Abstract available


  40. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    PubMed     Text format     Abstract available


  41. LEE N, Khalenkov AM, Lugovtsev VY, Ireland DD, et al
    The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.
    PLoS One. 2018;13:e0195525.
    PubMed     Text format     Abstract available


  42. BROGAARD L, Larsen LE, Heegaard PMH, Anthon C, et al
    IFN-lambda and microRNAs are important modulators of the pulmonary innate immune response against influenza A (H1N2) infection in pigs.
    PLoS One. 2018;13:e0194765.
    PubMed     Text format     Abstract available


  43. MARLET J, Gaudy-Graffin C, Marc D, Boennec R, et al
    Factors associated with influenza vaccination failure and severe disease in a French region in 2015.
    PLoS One. 2018;13:e0195611.
    PubMed     Text format     Abstract available


  44. SAHA S, Gupta V, Dawood FS, Broor S, et al
    Estimation of community-level influenza-associated illness in a low resource rural setting in India.
    PLoS One. 2018;13:e0196495.
    PubMed     Text format     Abstract available


  45. SEGOVIA KM, Franca MS, Leyson CL, Kapczynski DR, et al
    Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus.
    PLoS One. 2018;13:e0196394.
    PubMed     Text format     Abstract available


  46. OVIEDO DE LA FUENTE M, Febrero-Bande M, Munoz MP, Dominguez A, et al
    Predicting seasonal influenza transmission using functional regression models with temporal dependence.
    PLoS One. 2018;13:e0194250.
    PubMed     Text format     Abstract available


  47. MAITA H, Kobayashi T, Osawa H, Kato H, et al
    Self-diagnosis of seasonal influenza in a rural primary care setting in Japan: A cross sectional observational study.
    PLoS One. 2018;13:e0197163.
    PubMed     Text format     Abstract available


  48. WANG YF, Chang CF, Tsai HP, Chi CY, et al
    Glycan-binding preferences and genetic evolution of human seasonal influenza A(H3N2) viruses during 1999-2007 in Taiwan.
    PLoS One. 2018;13:e0196727.
    PubMed     Text format     Abstract available


  49. DESHEVA Y, Sychev I, Smolonogina T, Rekstin A, et al
    Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    PLoS One. 2018;13:e0196771.
    PubMed     Text format     Abstract available


  50. ESTRIN MA, Hussein ITM, Puryear WB, Kuan AC, et al
    Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells.
    PLoS One. 2018;13:e0197246.
    PubMed     Text format     Abstract available


  51. SHESHADRI A, Shah DP, Godoy M, Erasmus JJ, et al
    Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections.
    PLoS One. 2018;13:e0197418.
    PubMed     Text format     Abstract available


  52. MORRIS SE, Freiesleben de Blasio B, Viboud C, Wesolowski A, et al
    Analysis of multi-level spatial data reveals strong synchrony in seasonal influenza epidemics across Norway, Sweden, and Denmark.
    PLoS One. 2018;13:e0197519.
    PubMed     Text format     Abstract available


  53. KITTIKRAISAK W, Suntarattiwong P, Kanjanapattanakul W, Ditsungnoen D, et al
    Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015.
    PLoS One. 2018;13:e0197207.
    PubMed     Text format     Abstract available


  54. NEIRA V, Allerson M, Corzo C, Culhane M, et al
    Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.
    PLoS One. 2018;13:e0197600.
    PubMed     Text format     Abstract available


  55. PETUKHOVA T, Ojkic D, McEwen B, Deardon R, et al
    Assessment of autoregressive integrated moving average (ARIMA), generalized linear autoregressive moving average (GLARMA), and random forest (RF) time series regression models for predicting influenza A virus frequency in swine in Ontario, Canada.
    PLoS One. 2018;13:e0198313.
    PubMed     Text format     Abstract available


  56. VALLEY-OMAR Z, Iyengar P, von Mollendorf C, Tempia S, et al
    Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa.
    PLoS One. 2018;13:e0198101.
    PubMed     Text format     Abstract available


  57. WEI VWI, Wong JYT, Perera RAPM, Kwok KO, et al
    Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015.
    PLoS One. 2018;13:e0197504.
    PubMed     Text format     Abstract available


  58. IMAI C, Toizumi M, Hall L, Lambert S, et al
    A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    PLoS One. 2018;13:e0198685.
    PubMed     Text format     Abstract available


  59. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    PubMed     Text format     Abstract available


  60. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Text format     Abstract available


  61. KESINGER E, Liu J, Jensen A, Chia CP, et al
    Influenza D virus M2 protein exhibits ion channel activity in Xenopus laevis oocytes.
    PLoS One. 2018;13:e0199227.
    PubMed     Text format     Abstract available


  62. TROST JF, LeMasters EH, Liu F, Carney P, et al
    Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.
    PLoS One. 2018;13:e0199683.
    PubMed     Text format     Abstract available


  63. ZARNITSYNA VI, Bulusheva I, Handel A, Longini IM, et al
    Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.
    PLoS One. 2018;13:e0199674.
    PubMed     Text format     Abstract available


  64. DEBELLUT F, Hendrix N, Ortiz JR, Lambach P, et al
    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
    PLoS One. 2018;13:e0199470.
    PubMed     Text format     Abstract available


  65. ZHU R, Xu D, Yang X, Zhang J, et al
    Genetic and biological characterization of H9N2 avian influenza viruses isolated in China from 2011 to 2014.
    PLoS One. 2018;13:e0199260.
    PubMed     Text format     Abstract available


  66. KATO D, Kurebayashi Y, Takahashi T, Otsubo T, et al
    An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac.
    PLoS One. 2018;13:e0200761.
    PubMed     Text format     Abstract available


  67. CHUNG WC, Kang HR, Yoon H, Kang SJ, et al
    Correction: Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome.
    PLoS One. 2018;13:e0200624.
    PubMed     Text format     Abstract available


  68. ROOSENHOFF R, van der Vries E, van der Linden A, van Amerongen G, et al
    Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
    PLoS One. 2018;13:e0200849.
    PubMed     Text format     Abstract available


  69. SAMPAYO-ESCOBAR V, Green R, Cheung MB, Bedi R, et al
    Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection.
    PLoS One. 2018;13:e0192709.
    PubMed     Text format     Abstract available


  70. TIVANE A, Daniels R, Nguenha N, Machalele L, et al
    Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    PLoS One. 2018;13:e0201248.
    PubMed     Text format     Abstract available


  71. PATEL U, Gingerich A, Widman L, Sarr D, et al
    Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
    PLoS One. 2018;13:e0199167.
    PubMed     Text format     Abstract available


  72. WRONSKI S, Dannenmaier J, Schild S, Macke O, et al
    Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    PLoS One. 2018;13:e0195822.
    PubMed     Text format     Abstract available


  73. AGUSTININGSIH A, Trimarsanto H, Restuadi R, Artika IM, et al
    Evolutionary study and phylodynamic pattern of human influenza A/H3N2 virus in Indonesia from 2008 to 2010.
    PLoS One. 2018;13:e0201427.
    PubMed     Text format     Abstract available


  74. MACHABLISHVILI A, Chakhunashvili G, Zakhashvili K, Karseladze I, et al
    Overview of three influenza seasons in Georgia, 2014-2017.
    PLoS One. 2018;13:e0201207.
    PubMed     Text format     Abstract available


  75. MAZAGATOS C, Delgado-Sanz C, Oliva J, Gherasim A, et al
    Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    PLoS One. 2018;13:e0200934.
    PubMed     Text format     Abstract available


  76. FIELDHOUSE JK, Toh TH, Lim WH, Ting J, et al
    Surveillance for respiratory syncytial virus and parainfluenza virus among patients hospitalized with pneumonia in Sarawak, Malaysia.
    PLoS One. 2018;13:e0202147.
    PubMed     Text format     Abstract available


  77. TSYBALOVA LM, Stepanova LA, Shuklina MA, Mardanova ES, et al
    Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    PLoS One. 2018;13:e0201429.
    PubMed     Text format     Abstract available


  78. CHENG X, Chen T, Yang Y, Yang J, et al
    Using an innovative method to develop the threshold of seasonal influenza epidemic in China.
    PLoS One. 2018;13:e0202880.
    PubMed     Text format     Abstract available


  79. RULE AM, Apau O, Ahrenholz SH, Brueck SE, et al
    Healthcare personnel exposure in an emergency department during influenza season.
    PLoS One. 2018;13:e0203223.
    PubMed     Text format     Abstract available


  80. LOUGHRAN ST, Power PA, Maguire PT, McQuaid SL, et al
    Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-gamma responses to pneumococcus in vitro in human monocytes.
    PLoS One. 2018;13:e0203521.
    PubMed     Text format     Abstract available


  81. RYAN KA, Slack GS, Marriott AC, Kane JA, et al
    Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung.
    PLoS One. 2018;13:e0202675.
    PubMed     Text format     Abstract available


  82. FEDERICI C, Cavazza M, Costa F, Jommi C, et al
    Health care costs of influenza-related episodes in high income countries: A systematic review.
    PLoS One. 2018;13:e0202787.
    PubMed     Text format     Abstract available


  83. MATHEW S, Al Thani AA, Yassine HM
    Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.
    PLoS One. 2018;13:e0203148.
    PubMed     Text format     Abstract available


  84. DA COSTA ACC, Codeco CT, Krainski ET, Gomes MFDC, et al
    Spatiotemporal diffusion of influenza A (H1N1): Starting point and risk factors.
    PLoS One. 2018;13:e0202832.
    PubMed     Text format     Abstract available


  85. BONNEY PJ, Malladi S, Boender GJ, Weaver JT, et al
    Spatial transmission of H5N2 highly pathogenic avian influenza between Minnesota poultry premises during the 2015 outbreak.
    PLoS One. 2018;13:e0204262.
    PubMed     Text format     Abstract available


  86. KAVUNGA-MEMBO H, Nkwembe E, Simulundu E, Karhemere S, et al
    Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015.
    PLoS One. 2018;13:e0203995.
    PubMed     Text format     Abstract available


  87. ALLEN JD, Ray S, Ross TM
    Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2018;13:e0204284.
    PubMed     Text format     Abstract available


  88. KAWAHARA T, Akiba I, Sakou M, Sakaguchi T, et al
    Inactivation of human and avian influenza viruses by potassium oleate of natural soap component through exothermic interaction.
    PLoS One. 2018;13:e0204908.
    PubMed     Text format     Abstract available


  89. LU IN, Kirsteina A, Farinelle S, Willieme S, et al
    Structure and applications of novel influenza HA tri-stalk protein for evaluation of HA stem-specific immunity.
    PLoS One. 2018;13:e0204776.
    PubMed     Text format     Abstract available


  90. REIMAN JM, Das B, Sindberg GM, Urban MD, et al
    Humidity as a non-pharmaceutical intervention for influenza A.
    PLoS One. 2018;13:e0204337.
    PubMed     Text format     Abstract available


  91. ETBAIGHA F, R Willms A, Poljak Z
    An SEIR model of influenza A virus infection and reinfection within a farrow-to-finish swine farm.
    PLoS One. 2018;13:e0202493.
    PubMed     Text format     Abstract available


  92. LAU JTF, Ng CSM, Wu AMS, Ma YL, et al
    Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors.
    PLoS One. 2018;13:e0205561.
    PubMed     Text format     Abstract available


  93. WANG L, Jiang H, Shen SM, Wen CX, et al
    Inhibition of autophagy and chemokine induction by sphingosine 1-phosphate receptor 1 through NF-kappaB signaling in human pulmonary endothelial cells infected with influenza A viruses.
    PLoS One. 2018;13:e0205344.
    PubMed     Text format     Abstract available


  94. LI Z, Swann JL, Keskinocak P
    Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    PLoS One. 2018;13:e0206293.
    PubMed     Text format     Abstract available


  95. HOUSER KV, Yamshchikov GV, Bellamy AR, May J, et al
    DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    PLoS One. 2018;13:e0206837.
    PubMed     Text format     Abstract available


  96. ALKIE TN, Yitbarek A, Taha-Abdelaziz K, Astill J, et al
    Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    PLoS One. 2018;13:e0206324.
    PubMed     Text format     Abstract available


    January 2017
  97. REN ST, Zhang XM, Sun PF, Sun LJ, et al
    Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
    PLoS One. 2017;12:e0169501.
    PubMed     Text format     Abstract available



  98. Correction: Interleukin-7, but Not Thymic Stromal Lymphopoietin, Plays a Key Role in the T Cell Response to Influenza A Virus.
    PLoS One. 2017;12:e0169498.
    PubMed     Text format     Abstract available


  99. YOUNG-XU Y, van Aalst R, Russo E, Lee JK, et al
    The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population.
    PLoS One. 2017;12:e0169344.
    PubMed     Text format     Abstract available


  100. LU D, Qiao Y, Brown NE, Wang J, et al
    Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.
    PLoS One. 2017;12:e0169679.
    PubMed     Text format     Abstract available


  101. PERROTTA D, Bella A, Rizzo C, Paolotti D, et al
    Participatory Online Surveillance as a Supplementary Tool to Sentinel Doctors for Influenza-Like Illness Surveillance in Italy.
    PLoS One. 2017;12:e0169801.
    PubMed     Text format     Abstract available


  102. DARVISHIAN M, Dijkstra F, van Doorn E, Bijlsma MJ, et al
    Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    PLoS One. 2017;12:e0169528.
    PubMed     Text format     Abstract available


  103. VIRK RK, Gunalan V, Lee HK, Inoue M, et al
    Molecular Evidence of Transmission of Influenza A/H1N1 2009 on a University Campus.
    PLoS One. 2017;12:e0168596.
    PubMed     Text format     Abstract available


  104. PRAPHASIRI P, Ditsungneon D, Greenbaum A, Dawood FS, et al
    Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    PLoS One. 2017;12:e0169221.
    PubMed     Text format     Abstract available


  105. HOWARD LM, Hoek KL, Goll JB, Samir P, et al
    Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    PLoS One. 2017;12:e0167488.
    PubMed     Text format     Abstract available


  106. OONG XY, Ng KT, Tan JL, Chan KG, et al
    Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014.
    PLoS One. 2017;12:e0170610.
    PubMed     Text format     Abstract available


  107. DE SERRES G, Skowronski DM, Ward BJ, Gardam M, et al
    Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
    PLoS One. 2017;12:e0163586.
    PubMed     Text format     Abstract available


  108. HAYWARD AC
    Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients.
    PLoS One. 2017;12:e0169023.
    PubMed     Text format    


  109. SCHMID P, Rauber D, Betsch C, Lidolt G, et al
    Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.
    PLoS One. 2017;12:e0170550.
    PubMed     Text format     Abstract available


  110. TAN MC, Wong WY, Ng WL, Yeo KS, et al
    Identification of 5-Methoxy-2-(Diformylmethylidene)-3,3-Dimethylindole as an Anti-Influenza A Virus Agent.
    PLoS One. 2017;12:e0170352.
    PubMed     Text format     Abstract available


  111. WANG C, Wang Q, Hu J, Sun H, et al
    A Multiplex RT-PCR Assay for Detection and Differentiation of Avian-Origin Canine H3N2, Equine-Origin H3N8, Human-Origin H3N2, and H1N1/2009 Canine Influenza Viruses.
    PLoS One. 2017;12:e0170374.
    PubMed     Text format     Abstract available


  112. SEGOVIA KM, Stallknecht DE, Kapczynski DR, Stabler L, et al
    Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards.
    PLoS One. 2017;12:e0170335.
    PubMed     Text format     Abstract available


  113. ELAISH M, Ngunjiri JM, Ali A, Xia M, et al
    Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
    PLoS One. 2017;12:e0171174.
    PubMed     Text format     Abstract available


  114. PIPER K, Youk A, James AE 3rd, Kumar S, et al
    Paid sick days and stay-at-home behavior for influenza.
    PLoS One. 2017;12:e0170698.
    PubMed     Text format     Abstract available


  115. ZHANG A, Lai H, Xu J, Huang W, et al
    Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    PLoS One. 2017;12:e0170681.
    PubMed     Text format     Abstract available


  116. ORENSTEIN EW, Orenstein LA, Diarra K, Djiteye M, et al
    Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis.
    PLoS One. 2017;12:e0171499.
    PubMed     Text format     Abstract available


  117. XIA J, Cui JQ, He X, Liu YY, et al
    Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016.
    PLoS One. 2017;12:e0171564.
    PubMed     Text format     Abstract available


  118. TAN SY, Chowdhury S, Polak N, Gorrell MD, et al
    Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.
    PLoS One. 2017;12:e0171194.
    PubMed     Text format     Abstract available


  119. LIN SC, Kappes MA, Chen MC, Lin CC, et al
    Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.
    PLoS One. 2017;12:e0172299.
    PubMed     Text format     Abstract available


  120. GUTHRIE JL, Fisman D, Gardy JL
    Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma.
    PLoS One. 2017;12:e0172117.
    PubMed     Text format     Abstract available


  121. DONG W, Farooqui A, Leon AJ, Kelvin DJ, et al
    Inhibition of influenza A virus infection by ginsenosides.
    PLoS One. 2017;12:e0171936.
    PubMed     Text format     Abstract available


  122. DALGIC OO, Ozaltin OY, Ciccotelli WA, Erenay FS, et al
    Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.
    PLoS One. 2017;12:e0172261.
    PubMed     Text format     Abstract available


  123. SACZYNSKA V, Romanik A, Florys K, Cecuda-Adamczewska V, et al
    A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies.
    PLoS One. 2017;12:e0172008.
    PubMed     Text format     Abstract available


  124. KAWAGUCHI A, Suzuki T, Ohara Y, Takahashi K, et al
    Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection.
    PLoS One. 2017;12:e0173008.
    PubMed     Text format     Abstract available


  125. VERHAGEN JH, Lexmond P, Vuong O, Schutten M, et al
    Discordant detection of avian influenza virus subtypes in time and space between poultry and wild birds; Towards improvement of surveillance programs.
    PLoS One. 2017;12:e0173470.
    PubMed     Text format     Abstract available


  126. CHOI WS, Cowling BJ, Noh JY, Song JY, et al
    Disease burden of 2013-2014 seasonal influenza in adults in Korea.
    PLoS One. 2017;12:e0172012.
    PubMed     Text format     Abstract available


  127. ZHOU B, Li J, Liang X, Yang Z, et al
    Transcriptome profiling of influenza A virus-infected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatment.
    PLoS One. 2017;12:e0173058.
    PubMed     Text format     Abstract available


  128. MAKAU JN, Watanabe K, Ishikawa T, Mizuta S, et al
    Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.
    PLoS One. 2017;12:e0173582.
    PubMed     Text format     Abstract available


  129. KIM JI, Lee I, Park S, Bae JY, et al
    Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea.
    PLoS One. 2017;12:e0172059.
    PubMed     Text format     Abstract available


  130. DUQUE J, Gaga S, Clark D, Muller M, et al
    Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals.
    PLoS One. 2017;12:e0173983.
    PubMed     Text format     Abstract available


  131. NIANG MN, Diop NS, Fall A, Kiori DE, et al
    Respiratory viruses in patients with influenza-like illness in Senegal: Focus on human respiratory adenoviruses.
    PLoS One. 2017;12:e0174287.
    PubMed     Text format     Abstract available


  132. STRAUS MR, Whittaker GR
    A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
    PLoS One. 2017;12:e0174827.
    PubMed     Text format     Abstract available


  133. LADHANI L, Pardon G, Meeuws H, van Wesenbeeck L, et al
    Sampling and detection of airborne influenza virus towards point-of-care applications.
    PLoS One. 2017;12:e0174314.
    PubMed     Text format     Abstract available


  134. CAINI S, Alonso WJ, Balmaseda A, Bruno A, et al
    Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries.
    PLoS One. 2017;12:e0174592.
    PubMed     Text format     Abstract available


  135. WOLKEWITZ M, Schumacher M
    Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.
    PLoS One. 2017;12:e0175660.
    PubMed     Text format     Abstract available


  136. MANCERA GRACIA JC, Van den Hoecke S, Saelens X, Van Reeth K, et al
    Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine.
    PLoS One. 2017;12:e0175267.
    PubMed     Text format     Abstract available


  137. YE Y, Wagner MM, Cooper GF, Ferraro JP, et al
    A study of the transferability of influenza case detection systems between two large healthcare systems.
    PLoS One. 2017;12:e0174970.
    PubMed     Text format     Abstract available


  138. HUANG DT, Lu CY, Shao PL, Chang LY, et al
    In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery.
    PLoS One. 2017;12:e0174523.
    PubMed     Text format     Abstract available


  139. BUI CM, Gardner L, MacIntyre R, Sarkar S, et al
    Influenza A H5N1 and H7N9 in China: A spatial risk analysis.
    PLoS One. 2017;12:e0174980.
    PubMed     Text format     Abstract available


  140. TEWAWONG N, Vichiwattana P, Korkong S, Klinfueng S, et al
    Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.
    PLoS One. 2017;12:e0175655.
    PubMed     Text format     Abstract available


  141. JIANG H, Shen SM, Yin J, Zhang PP, et al
    Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses.
    PLoS One. 2017;12:e0175188.
    PubMed     Text format     Abstract available


  142. DANNEMILLER NG, Webb CT, Wilson KR, Bentler KT, et al
    Impact of body condition on influenza A virus infection dynamics in mallards following a secondary exposure.
    PLoS One. 2017;12:e0175757.
    PubMed     Text format     Abstract available


  143. VERMA S, Soto J, Vasudevan A, Schmeisser F, et al
    Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    PLoS One. 2017;12:e0175733.
    PubMed     Text format     Abstract available


  144. SACZYNSKA V, Romanik A, Florys K, Cecuda-Adamczewska V, et al
    Correction: A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies.
    PLoS One. 2017;12:e0176249.
    PubMed     Text format     Abstract available


  145. BUI CM, Gardner L, MacIntyre CR, Sarkar S, et al
    Correction: Influenza A H5N1 and H7N9 in China: A spatial risk analysis.
    PLoS One. 2017;12:e0176903.
    PubMed     Text format     Abstract available


  146. MEYER L, Leymarie O, Chevalier C, Esnault E, et al
    Transcriptomic profiling of a chicken lung epithelial cell line (CLEC213) reveals a mitochondrial respiratory chain activity boost during influenza virus infection.
    PLoS One. 2017;12:e0176355.
    PubMed     Text format     Abstract available


  147. FERNANDES-MATANO L, Monroy-Munoz IE, Angeles-Martinez J, Sarquiz-Martinez B, et al
    Prevalence of non-influenza respiratory viruses in acute respiratory infection cases in Mexico.
    PLoS One. 2017;12:e0176298.
    PubMed     Text format     Abstract available


  148. WIJNANS L, Dodd CN, Weibel D, Sturkenboom M, et al
    Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    PLoS One. 2017;12:e0175539.
    PubMed     Text format     Abstract available


  149. XU Q, Gel YR, Ramirez Ramirez LL, Nezafati K, et al
    Forecasting influenza in Hong Kong with Google search queries and statistical model fusion.
    PLoS One. 2017;12:e0176690.
    PubMed     Text format     Abstract available


  150. HUIPAO N, Borwornpinyo S, Wiboon-Ut S, Campbell CR, et al
    P2Y6 receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium.
    PLoS One. 2017;12:e0176974.
    PubMed     Text format     Abstract available


  151. ZMORA P, Molau-Blazejewska P, Bertram S, Walendy-Gnirss K, et al
    Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.
    PLoS One. 2017;12:e0176597.
    PubMed     Text format     Abstract available


  152. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Text format     Abstract available


  153. PANTIN-JACKWOOD MJ, Stephens CB, Bertran K, Swayne DE, et al
    The pathogenesis of H7N8 low and highly pathogenic avian influenza viruses from the United States 2016 outbreak in chickens, turkeys and mallards.
    PLoS One. 2017;12:e0177265.
    PubMed     Text format     Abstract available


  154. PAPP Z, Clark RG, Parmley EJ, Leighton FA, et al
    The ecology of avian influenza viruses in wild dabbling ducks (Anas spp.) in Canada.
    PLoS One. 2017;12:e0176297.
    PubMed     Text format     Abstract available


  155. HAUSE AM, Henke DM, Avadhanula V, Shaw CA, et al
    Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
    PLoS One. 2017;12:e0175792.
    PubMed     Text format     Abstract available


  156. NOH JY, Lim S, Song JY, Choi WS, et al
    Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
    PLoS One. 2017;12:e0178010.
    PubMed     Text format     Abstract available


  157. CHEN T, Huang Y, Liu R, Xie Z, et al
    Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study.
    PLoS One. 2017;12:e0177672.
    PubMed     Text format     Abstract available


  158. YIN S, Kleijn D, Muskens GJDM, Fouchier RAM, et al
    No evidence that migratory geese disperse avian influenza viruses from breeding to wintering ground.
    PLoS One. 2017;12:e0177790.
    PubMed     Text format     Abstract available


  159. SELEKA M, Treurnicht FK, Tempia S, Hellferscee O, et al
    Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.
    PLoS One. 2017;12:e0177655.
    PubMed     Text format     Abstract available


  160. ZHANG Z, Liu D, Sun W, Liu J, et al
    Multiplex one-step Real-time PCR by Taqman-MGB method for rapid detection of pan and H5 subtype avian influenza viruses.
    PLoS One. 2017;12:e0178634.
    PubMed     Text format     Abstract available


  161. LI X, Tian B, Jianfang Z, Yongkun C, et al
    A comprehensive retrospective study of the seroprevalence of H9N2 avian influenza viruses in occupationally exposed populations in China.
    PLoS One. 2017;12:e0178328.
    PubMed     Text format     Abstract available


  162. PIRALLA A, Rovida F, Girello A, Premoli M, et al
    Frequency of respiratory virus infections and next-generation analysis of influenza A/H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU.
    PLoS One. 2017;12:e0178926.
    PubMed     Text format     Abstract available


  163. BAUDON E, Peyre M, Peiris M, Cowling BJ, et al
    Epidemiological features of influenza circulation in swine populations: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179044.
    PubMed     Text format     Abstract available


  164. BAHAROM F, Thomas OS, Lepzien R, Mellman I, et al
    Visualization of early influenza A virus trafficking in human dendritic cells using STED microscopy.
    PLoS One. 2017;12:e0177920.
    PubMed     Text format     Abstract available


  165. GHERASIM A, Martinez-Baz I, Castilla J, Pozo F, et al
    Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    PLoS One. 2017;12:e0179160.
    PubMed     Text format     Abstract available


  166. SAUNDERS-HASTINGS P, Quinn Hayes B, Smith R, Krewski D, et al
    Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.
    PLoS One. 2017;12:e0179315.
    PubMed     Text format     Abstract available


  167. MEYER A, Dinh TX, Nhu TV, Pham LT, et al
    Movement and contact patterns of long-distance free-grazing ducks and avian influenza persistence in Vietnam.
    PLoS One. 2017;12:e0178241.
    PubMed     Text format     Abstract available


  168. AFANADOR-VILLAMIZAR A, Gomez-Romero C, Diaz A, Ruiz-Saenz J, et al
    Avian influenza in Latin America: A systematic review of serological and molecular studies from 2000-2015.
    PLoS One. 2017;12:e0179573.
    PubMed     Text format     Abstract available


  169. MANCEUR AP, Zou W, Marcil A, Paquet E, et al
    Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
    PLoS One. 2017;12:e0180314.
    PubMed     Text format     Abstract available


  170. WILSON G, Ye Z, Xie H, Vahl S, et al
    Automated interpretation of influenza hemagglutination inhibition (HAI) assays: Is plate tilting necessary?
    PLoS One. 2017;12:e0179939.
    PubMed     Text format     Abstract available


  171. EMUKULE GO, Spreeuwenberg P, Chaves SS, Mott JA, et al
    Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
    PLoS One. 2017;12:e0180890.
    PubMed     Text format     Abstract available


  172. MATYUSHENKO V, Isakova-Sivak I, Smolonogina T, Dubrovina I, et al
    Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine.
    PLoS One. 2017;12:e0180497.
    PubMed     Text format     Abstract available


  173. MUKHERJEE S, Subramaniam R, Chen H, Smith A, et al
    Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia.
    PLoS One. 2017;12:e0180143.
    PubMed     Text format     Abstract available


  174. VON DER BECK D, Seeger W, Herold S, Gunther A, et al
    Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data.
    PLoS One. 2017;12:e0180920.
    PubMed     Text format     Abstract available


  175. HUANG ZZ, Yu L, Huang P, Liang LJ, et al
    Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.
    PLoS One. 2017;12:e0178231.
    PubMed     Text format     Abstract available


  176. YU D, Lin Q, Chiu AP, He D, et al
    Effects of reactive social distancing on the 1918 influenza pandemic.
    PLoS One. 2017;12:e0180545.
    PubMed     Text format     Abstract available


  177. STERVBO U, Pohlmann D, Baron U, Bozzetti C, et al
    Age dependent differences in the kinetics of gammadelta T cells after influenza vaccination.
    PLoS One. 2017;12:e0181161.
    PubMed     Text format     Abstract available


  178. DOBROVOLNY HM, Beauchemin CAA
    Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.
    PLoS One. 2017;12:e0180582.
    PubMed     Text format     Abstract available


  179. ARELLANO-LLAMAS R, Alfaro-Ruiz L, Arriaga Canon C, Imaz Rosshandler I, et al
    Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014.
    PLoS One. 2017;12:e0180419.
    PubMed     Text format     Abstract available


  180. TE BEEST DE, de Bruin E, Imholz S, Koopmans M, et al
    Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).
    PLoS One. 2017;12:e0181093.
    PubMed     Text format     Abstract available


  181. HARTLEY DM, Giannini CM, Wilson S, Frieder O, et al
    Coughing, sneezing, and aching online: Twitter and the volume of influenza-like illness in a pediatric hospital.
    PLoS One. 2017;12:e0182008.
    PubMed     Text format     Abstract available


  182. YOU JHS, Tam LP, Lee NLS
    Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting.
    PLoS One. 2017;12:e0182091.
    PubMed     Text format     Abstract available


  183. ILYUSHINA NA, Lugovtsev VY, Samsonova AP, Sheikh FG, et al
    Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
    PLoS One. 2017;12:e0181999.
    PubMed     Text format     Abstract available


  184. WU H, Wang X, Xue M, Xue M, et al
    Spatial characteristics and the epidemiology of human infections with avian influenza A(H7N9) virus in five waves from 2013 to 2017 in Zhejiang Province, China.
    PLoS One. 2017;12:e0180763.
    PubMed     Text format     Abstract available


  185. XU L, Qin Y, Yang J, Han W, et al
    Coverage and factors associated with influenza vaccination among kindergarten children 2-7 years old in a low-income city of north-western China (2014-2016).
    PLoS One. 2017;12:e0181539.
    PubMed     Text format     Abstract available


  186. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Text format     Abstract available


  187. NGUYEN LT, Nakaishi K, Motojima K, Ohkawara A, et al
    Rapid and broad detection of H5 hemagglutinin by an immunochromatographic kit using novel monoclonal antibody against highly pathogenic avian influenza virus belonging to the genetic clade 2.3.4.4.
    PLoS One. 2017;12:e0182228.
    PubMed     Text format     Abstract available


  188. CHEN WA, Zhang J, Hall KM, Martin CB, et al
    Addition of alphaGal HyperAcute technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
    PLoS One. 2017;12:e0182683.
    PubMed     Text format     Abstract available


  189. OMAR S, Clarke R, Abdullah H, Brady C, et al
    Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells.
    PLoS One. 2017;12:e0171681.
    PubMed     Text format     Abstract available


  190. PARK JY, Kim BJ, Lee EJ, Park KS, et al
    Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel.
    PLoS One. 2017;12:e0170592.
    PubMed     Text format     Abstract available


  191. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available


  192. CASALINO E, Antoniol S, Fidouh N, Choquet C, et al
    Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.
    PLoS One. 2017;12:e0182191.
    PubMed     Text format     Abstract available


  193. XING W, Barauskas O, Kirschberg T, Niedziela-Majka A, et al
    Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
    PLoS One. 2017;12:e0181969.
    PubMed     Text format     Abstract available


  194. ENGELMANN I, Dewilde A, Lazrek M, Batteux M, et al
    In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients.
    PLoS One. 2017;12:e0170774.
    PubMed     Text format     Abstract available


  195. JANS J, Wicht O, Widjaja I, Ahout IM, et al
    Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
    PLoS One. 2017;12:e0170877.
    PubMed     Text format     Abstract available


  196. ZHANG A, Wang D, Li J, Gao F, et al
    The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity.
    PLoS One. 2017;12:e0183720.
    PubMed     Text format     Abstract available


  197. LIAO LE, Kowal S, Cardenas DA, Beauchemin CAA, et al
    Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.
    PLoS One. 2017;12:e0183621.
    PubMed     Text format     Abstract available


  198. SPIVEY TJ, Lindberg MS, Meixell BW, Smith KR, et al
    Maintenance of influenza A viruses and antibody response in mallards (Anas platyrhynchos) sampled during the non-breeding season in Alaska.
    PLoS One. 2017;12:e0183505.
    PubMed     Text format     Abstract available


  199. KITTIKRAISAK W, Suntarattiwong P, Ditsungnoen D, Pallas SE, et al
    Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children </=60 months of age.
    PLoS One. 2017;12:e0183391.
    PubMed     Text format     Abstract available


  200. SUPTAWIWAT O, Ruangrung K, Boonarkart C, Puthavathana P, et al
    Microparticle and anti-influenza activity in human respiratory secretion.
    PLoS One. 2017;12:e0183717.
    PubMed     Text format     Abstract available


  201. FRIEDMAN D, Fryzek J, Jiang X, Bloomfield A, et al
    Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.
    PLoS One. 2017;12:e0172512.
    PubMed     Text format     Abstract available


  202. BROWN PM, Harford TJ, Agrawal V, Yen-Lieberman B, et al
    Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life Reinfections.
    PLoS One. 2017;12:e0168786.
    PubMed     Text format     Abstract available


  203. MOE N, Krokstad S, Stenseng IH, Christensen A, et al
    Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
    PLoS One. 2017;12:e0170200.
    PubMed     Text format     Abstract available


  204. HUANG HC, Singh B, Morton DP, Johnson GP, et al
    Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points.
    PLoS One. 2017;12:e0182720.
    PubMed     Text format     Abstract available


  205. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    PubMed     Text format     Abstract available


  206. BHUYAN GS, Hossain MA, Sarker SK, Rahat A, et al
    Bacterial and viral pathogen spectra of acute respiratory infections in under-5 children in hospital settings in Dhaka city.
    PLoS One. 2017;12:e0174488.
    PubMed     Text format     Abstract available


  207. TIAN DD, Jiang R, Chen XJ, Ye Q, et al
    Meteorological factors on the incidence of MP and RSV pneumonia in children.
    PLoS One. 2017;12:e0173409.
    PubMed     Text format     Abstract available


  208. PIEDRA FA, Mei M, Avadhanula V, Mehta R, et al
    The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
    PLoS One. 2017;12:e0172953.
    PubMed     Text format     Abstract available


  209. VELDHOEN ES, Smulders CA, Kappen TH, Calis JC, et al
    Post-extubation stridor in Respiratory Syncytial Virus bronchiolitis: Is there a role for prophylactic dexamethasone?
    PLoS One. 2017;12:e0172096.
    PubMed     Text format     Abstract available


  210. XU W, Chen T, Dong X, Kong M, et al
    Outbreak detection and evaluation of a school-based influenza-like-illness syndromic surveillance in Tianjin, China.
    PLoS One. 2017;12:e0184527.
    PubMed     Text format     Abstract available


  211. HU J, Xu X, Wang C, Bing G, et al
    Isolation and characterization of H4N6 avian influenza viruses from mallard ducks in Beijing, China.
    PLoS One. 2017;12:e0184437.
    PubMed     Text format     Abstract available


  212. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    PubMed     Text format     Abstract available


  213. NYIRO JU, Kombe IK, Sande CJ, Kipkoech J, et al
    Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
    PLoS One. 2017;12:e0177803.
    PubMed     Text format     Abstract available


  214. OH J, Lee S, Lee H, Cho JY, et al
    The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
    PLoS One. 2017;12:e0176320.
    PubMed     Text format     Abstract available


  215. CLAYDON J, Sur A, Callejas A, Ladd M, et al
    Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen.
    PLoS One. 2017;12:e0176152.
    PubMed     Text format     Abstract available


  216. FONCECA AM, Chopra A, Levy A, Noakes PS, et al
    Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months.
    PLoS One. 2017;12:e0173738.
    PubMed     Text format     Abstract available


  217. LEE JY, Chang J
    Universal vaccine against respiratory syncytial virus A and B subtypes.
    PLoS One. 2017;12:e0175384.
    PubMed     Text format     Abstract available


  218. VISSEAUX B, Collin G, Ichou H, Charpentier C, et al
    Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study.
    PLoS One. 2017;12:e0172809.
    PubMed     Text format     Abstract available


  219. CHROMIKOVA V, Zaragoza MA, Krammer F
    Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.
    PLoS One. 2017;12:e0183315.
    PubMed     Text format     Abstract available


  220. BOYD M, Baker MG, Mansoor OD, Kvizhinadze G, et al
    Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention.
    PLoS One. 2017;12:e0178732.
    PubMed     Text format     Abstract available


  221. BELKACEM N, Serafini N, Wheeler R, Derrien M, et al
    Lactobacillus paracasei feeding improves immune control of influenza infection in mice.
    PLoS One. 2017;12:e0184976.
    PubMed     Text format     Abstract available


  222. LEE SY, Noh Y, Goo JH, Rho S, et al
    Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice.
    PLoS One. 2017;12:e0176940.
    PubMed     Text format     Abstract available


  223. REZA ETEMADI M, Ling KH, Zainal Abidin S, Chee HY, et al
    Gene expression patterns induced at different stages of rhinovirus infection in human alveolar epithelial cells.
    PLoS One. 2017;12:e0176947.
    PubMed     Text format     Abstract available


  224. HEYMANN PW, Nguyen HT, Steinke JW, Turner RB, et al
    Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescence.
    PLoS One. 2017;12:e0178096.
    PubMed     Text format     Abstract available


  225. LEWANDOWSKA DW, Schreiber PW, Schuurmans MM, Ruehe B, et al
    Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection.
    PLoS One. 2017;12:e0177340.
    PubMed     Text format     Abstract available


  226. TIEN SH, Crabtree JN, Gray HL, Peterson EJ, et al
    Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.
    PLoS One. 2017;12:e0181338.
    PubMed     Text format     Abstract available


  227. NYOKA R, Omony J, Mwalili SM, Achia TNO, et al
    Effect of climate on incidence of respiratory syncytial virus infections in a refugee camp in Kenya: A non-Gaussian time-series analysis.
    PLoS One. 2017;12:e0178323.
    PubMed     Text format     Abstract available


  228. COLOSIA AD, Yang J, Hillson E, Mauskopf J, et al
    The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.
    PLoS One. 2017;12:e0182321.
    PubMed     Text format     Abstract available


  229. LANDI D, Albanese M, Buttari F, Monteleone F, et al
    Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.
    PLoS One. 2017;12:e0165415.
    PubMed     Text format     Abstract available


  230. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Text format     Abstract available


  231. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Text format     Abstract available


  232. BARAUSKAS O, Xing W, Aguayo E, Willkom M, et al
    Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs.
    PLoS One. 2017;12:e0185998.
    PubMed     Text format     Abstract available


  233. VANLEUVEN JT, Ridenhour BJ, Gonzalez AJ, Miller CR, et al
    Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses.
    PLoS One. 2017;12:e0178408.
    PubMed     Text format     Abstract available


  234. EGARNES B, Blanchet MR, Gosselin J
    Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice.
    PLoS One. 2017;12:e0186639.
    PubMed     Text format     Abstract available


  235. PIRALLA A, Lunghi G, Ruggiero L, Girello A, et al
    Molecular epidemiology of influenza B virus among hospitalized pediatric patients in Northern Italy during the 2015-16 season.
    PLoS One. 2017;12:e0185893.
    PubMed     Text format     Abstract available


  236. JUNG JJ, Pinto R, Zarychanski R, Cook DJ, et al
    2009-2010 Influenza A(H1N1)-related critical illness among Aboriginal and non-Aboriginal Canadians.
    PLoS One. 2017;12:e0184013.
    PubMed     Text format     Abstract available


  237. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Text format     Abstract available


  238. UPTON N, Jackson DJ, Nikonova AA, Hingley-Wilson S, et al
    Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.
    PLoS One. 2017;12:e0183864.
    PubMed     Text format     Abstract available


  239. ZHANG S, Wu Y, Xuan Z, Chen X, et al
    Screening differential miRNAs responsible for permeability increase in HUVECs infected with influenza A virus.
    PLoS One. 2017;12:e0186477.
    PubMed     Text format     Abstract available


  240. LEVITZ R, Gao Y, Dozmorov I, Song R, et al
    Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus.
    PLoS One. 2017;12:e0184318.
    PubMed     Text format     Abstract available


  241. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Text format     Abstract available


  242. MONAMELE GC, Vernet MA, Nsaibirni RFJ, Bigna JJR, et al
    Associations between meteorological parameters and influenza activity in a subtropical country: Case of five sentinel sites in Yaounde-Cameroon.
    PLoS One. 2017;12:e0186914.
    PubMed     Text format     Abstract available


  243. PAUNGPIN W, Wiriyarat W, Chaichoun K, Tiyanun E, et al
    Serosurveillance for pandemic influenza A (H1N1) 2009 virus infection in domestic elephants, Thailand.
    PLoS One. 2017;12:e0186962.
    PubMed     Text format     Abstract available


  244. BARLOW-ANACKER A, Bochkov Y, Gern J, Seroogy CM, et al
    Neonatal immune response to rhinovirus A16 has diminished dendritic cell function and increased B cell activation.
    PLoS One. 2017;12:e0180664.
    PubMed     Text format     Abstract available


  245. JEE PF, Tiong V, Shu MH, Khoo JJ, et al
    Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    PLoS One. 2017;12:e0187718.
    PubMed     Text format     Abstract available


  246. HAGGLUND S, Blodorn K, Naslund K, Vargmar K, et al
    Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus-Insights in pathogenesis and perspectives for new treatments.
    PLoS One. 2017;12:e0186594.
    PubMed     Text format     Abstract available


  247. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Text format     Abstract available


  248. CLARK AM, DeDiego ML, Anderson CS, Wang J, et al
    Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
    PLoS One. 2017;12:e0188267.
    PubMed     Text format     Abstract available


  249. CHANG CK, Chen CJ, Wu CC, Chen SW, et al
    Cellular hnRNP A2/B1 interacts with the NP of influenza A virus and impacts viral replication.
    PLoS One. 2017;12:e0188214.
    PubMed     Text format     Abstract available


  250. SAVIC M, Dembinski JL, Laake I, Hungnes O, et al
    Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.
    PLoS One. 2017;12:e0188055.
    PubMed     Text format     Abstract available


  251. PALE M, Nacoto A, Tivane A, Nguenha N, et al
    Respiratory syncytial and influenza viruses in children under 2 years old with severe acute respiratory infection (SARI) in Maputo, 2015.
    PLoS One. 2017;12:e0186735.
    PubMed     Text format     Abstract available


  252. PRAPHASIRI P, Ditsungnoen D, Sirilak S, Rattanayot J, et al
    Predictors of seasonal influenza vaccination among older adults in Thailand.
    PLoS One. 2017;12:e0188422.
    PubMed     Text format     Abstract available


  253. LI H, Callahan C, Citron M, Wen Z, et al
    Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
    PLoS One. 2017;12:e0187642.
    PubMed     Text format     Abstract available


  254. CANCHE-PECH JR, Conde-Ferraez L, Puerto-Solis M, Gonzalez-Losa R, et al
    Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.
    PLoS One. 2017;12:e0189363.
    PubMed     Text format     Abstract available


  255. KOIRE A, Gilbert BE, Sucgang R, Zechiedrich L, et al
    Correction: Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice.
    PLoS One. 2017;12:e0189384.
    PubMed     Text format     Abstract available


  256. BRINI I, Guerrero A, Hannachi N, Bouguila J, et al
    Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia.
    PLoS One. 2017;12:e0188325.
    PubMed     Text format     Abstract available


  257. VOLKOVA S, Ayton E, Porterfield K, Corley CD, et al
    Forecasting influenza-like illness dynamics for military populations using neural networks and social media.
    PLoS One. 2017;12:e0188941.
    PubMed     Text format     Abstract available


  258. RAJARAM S, Wiecek W, Lawson R, Blak BT, et al
    Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    PLoS One. 2017;12:e0186739.
    PubMed     Text format     Abstract available


  259. MCMORROW ML, Emukule GO, Obor D, Nyawanda B, et al
    Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?
    PLoS One. 2017;12:e0189623.
    PubMed     Text format     Abstract available


  260. PECENKA C, Munthali S, Chunga P, Levin A, et al
    Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.
    PLoS One. 2017;12:e0190006.
    PubMed     Text format     Abstract available


  261. KODAY MT, Leonard JA, Munson P, Forero A, et al
    Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
    PLoS One. 2017;12:e0189780.
    PubMed     Text format     Abstract available


  262. SUNTRONWONG N, Klinfueng S, Vichiwattana P, Korkong S, et al
    Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    PLoS One. 2017;12:e0189511.
    PubMed     Text format     Abstract available


  263. GARCIA-GARCIA ML, Calvo C, Ruiz S, Pozo F, et al
    Role of viral coinfections in asthma development.
    PLoS One. 2017;12:e0189083.
    PubMed     Text format     Abstract available


  264. CAYATTE C, Snell Bennett A, Rajani GM, Hostetler L, et al
    Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    PLoS One. 2017;12:e0188708.
    PubMed     Text format     Abstract available


  265. ROTH M, Pasquali C, Stolz D, Tamm M, et al
    Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP.
    PLoS One. 2017;12:e0188010.
    PubMed     Text format     Abstract available


  266. DIETERT K, Gutbier B, Wienhold SM, Reppe K, et al
    Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia.
    PLoS One. 2017;12:e0188251.
    PubMed     Text format     Abstract available


    January 2016
  267. BUTLER J, Stewart CR, Layton DS, Phommachanh P, et al
    Novel Reassortant H5N6 Influenza A Virus from the Lao People's Democratic Republic Is Highly Pathogenic in Chickens.
    PLoS One. 2016;11:e0162375.
    PubMed     Text format     Abstract available


  268. VERSCHOOR CP, Singh P, Russell ML, Bowdish DM, et al
    Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children.
    PLoS One. 2016;11:e0163830.
    PubMed     Text format     Abstract available


  269. ZHAO J, Liu J, Vemula SV, Lin C, et al
    Sensitive Detection and Simultaneous Discrimination of Influenza A and B Viruses in Nasopharyngeal Swabs in a Single Assay Using Next-Generation Sequencing-Based Diagnostics.
    PLoS One. 2016;11:e0163175.
    PubMed     Text format     Abstract available


  270. BROTTET E, Jaffar-Bandjee MC, Li-Pat-Yuen G, Filleul L, et al
    Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in Reunion Island, 2011-2012.
    PLoS One. 2016;11:e0163377.
    PubMed     Text format     Abstract available


  271. SALK HM, Simon WL, Lambert ND, Kennedy RB, et al
    Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine.
    PLoS One. 2016;11:e0162803.
    PubMed     Text format     Abstract available


  272. WANG C, Lee HH, Yang ZF, Mok CK, et al
    PB2-Q591K Mutation Determines the Pathogenicity of Avian H9N2 Influenza Viruses for Mammalian Species.
    PLoS One. 2016;11:e0162163.
    PubMed     Text format     Abstract available


  273. SPRUIJT IT, de Lange MM, Dijkstra F, Donker GA, et al
    Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.
    PLoS One. 2016;11:e0163508.
    PubMed     Text format     Abstract available


  274. HORIMOTO T, Hiono T, Mekata H, Odagiri T, et al
    Nationwide Distribution of Bovine Influenza D Virus Infection in Japan.
    PLoS One. 2016;11:e0163828.
    PubMed     Text format     Abstract available


  275. CADOR C, Rose N, Willem L, Andraud M, et al
    Maternally Derived Immunity Extends Swine Influenza A Virus Persistence within Farrow-to-Finish Pig Farms: Insights from a Stochastic Event-Driven Metapopulation Model.
    PLoS One. 2016;11:e0163672.
    PubMed     Text format     Abstract available


  276. XU X, Greenland JR, Gotts JE, Matthay MA, et al
    Cathepsin L Helps to Defend Mice from Infection with Influenza A.
    PLoS One. 2016;11:e0164501.
    PubMed     Text format     Abstract available


  277. ROUXEL RN, Merour E, Biacchesi S, Bremont M, et al
    Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.
    PLoS One. 2016;11:e0164245.
    PubMed     Text format     Abstract available


  278. KUMAR D, Broor S, Rajala MS
    Interaction of Host Nucleolin with Influenza A Virus Nucleoprotein in the Early Phase of Infection Limits the Late Viral Gene Expression.
    PLoS One. 2016;11:e0164146.
    PubMed     Text format     Abstract available


  279. ZURCHER K, Zwahlen M, Ballif M, Rieder HL, et al
    Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.
    PLoS One. 2016;11:e0162575.
    PubMed     Text format     Abstract available


  280. LEE DW, Hsu HL, Bacon KB, Daniel S, et al
    Image Restoration and Analysis of Influenza Virions Binding to Membrane Receptors Reveal Adhesion-Strengthening Kinetics.
    PLoS One. 2016;11:e0163437.
    PubMed     Text format     Abstract available


  281. SHA J, Dong W, Liu S, Chen X, et al
    Differences in the Epidemiology of Childhood Infections with Avian Influenza A H7N9 and H5N1 Viruses.
    PLoS One. 2016;11:e0161925.
    PubMed     Text format     Abstract available


  282. DALZIEL AE, Delean S, Heinrich S, Cassey P, et al
    Persistence of Low Pathogenic Influenza A Virus in Water: A Systematic Review and Quantitative Meta-Analysis.
    PLoS One. 2016;11:e0161929.
    PubMed     Text format     Abstract available


  283. WABWIRE-MANGEN F, Mimbe DE, Erima B, Mworozi EA, et al
    Epidemiology and Surveillance of Influenza Viruses in Uganda between 2008 and 2014.
    PLoS One. 2016;11:e0164861.
    PubMed     Text format     Abstract available


  284. REILLY EC, Lambert-Emo K, Topham DJ
    The Effects of Acute Neutrophil Depletion on Resolution of Acute Influenza Infection, Establishment of Tissue Resident Memory (TRM), and Heterosubtypic Immunity.
    PLoS One. 2016;11:e0164247.
    PubMed     Text format     Abstract available


  285. KOIRE A, Gilbert BE, Sucgang R, Zechiedrich L, et al
    Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice.
    PLoS One. 2016;11:e0165729.
    PubMed     Text format     Abstract available


  286. SPACKMAN E, Cardona C, Munoz-Aguayo J, Fleming S, et al
    Successes and Short Comings in Four Years of an International External Quality Assurance Program for Animal Influenza Surveillance.
    PLoS One. 2016;11:e0164261.
    PubMed     Text format     Abstract available


  287. ILYICHEVA T, Durymanov A, Susloparov I, Kolosova N, et al
    Fatal Cases of Seasonal Influenza in Russia in 2015-2016.
    PLoS One. 2016;11:e0165332.
    PubMed     Text format     Abstract available


  288. LAZARUS R, Kelly S, Snape MD, Vandermeulen C, et al
    Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
    PLoS One. 2016;11:e0165384.
    PubMed     Text format     Abstract available


  289. KERVIEL A, Dash S, Moncorge O, Panthu B, et al
    Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus.
    PLoS One. 2016;11:e0165421.
    PubMed     Text format     Abstract available


  290. VIDY A, Maisonnasse P, Da Costa B, Delmas B, et al
    The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition.
    PLoS One. 2016;11:e0165361.
    PubMed     Text format     Abstract available


  291. FABIANI M, Riccardo F, Di Napoli A, Gargiulo L, et al
    Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study.
    PLoS One. 2016;11:e0166517.
    PubMed     Text format     Abstract available


  292. MINCHOLE E, Figueredo AL, Omenaca M, Panadero C, et al
    Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    PLoS One. 2016;11:e0165711.
    PubMed     Text format     Abstract available


  293. NYIRENDA M, Omori R, Tessmer HL, Arimura H, et al
    Estimating the Lineage Dynamics of Human Influenza B Viruses.
    PLoS One. 2016;11:e0166107.
    PubMed     Text format     Abstract available


  294. VELJKOVIC V, Veljkovic N, Paessler S, Goeijenbier M, et al
    Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.
    PLoS One. 2016;11:e0165451.
    PubMed     Text format     Abstract available


  295. TAN D, Zhu H, Fu Y, Tong F, et al
    Severe Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults: A Multicenter Case Series.
    PLoS One. 2016;11:e0151199.
    PubMed     Text format     Abstract available


  296. FLOOD A, Estrada M, McAdams D, Ji Y, et al
    Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    PLoS One. 2016;11:e0164692.
    PubMed     Text format     Abstract available


  297. ROBERTSON C, Yee L
    Avian Influenza Risk Surveillance in North America with Online Media.
    PLoS One. 2016;11:e0165688.
    PubMed     Text format     Abstract available


  298. CHEN T, Chen T, Liu R, Xu C, et al
    Transmissibility of the Influenza Virus during Influenza Outbreaks and Related Asymptomatic Infection in Mainland China, 2005-2013.
    PLoS One. 2016;11:e0166180.
    PubMed     Text format     Abstract available


  299. BOSE ME, McCaul KC, Mei H, Sasman A, et al
    Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays.
    PLoS One. 2016;11:e0166800.
    PubMed     Text format     Abstract available


  300. LEGA T, Weiher P, Obuchowski M, Nidzworski D, et al
    Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis.
    PLoS One. 2016;11:e0167225.
    PubMed     Text format     Abstract available


  301. PERWITASARI O, Johnson S, Yan X, Register E, et al
    Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
    PLoS One. 2016;11:e0167221.
    PubMed     Text format     Abstract available


  302. QI L, Xiong Y, Xiao B, Tang W, et al
    Epidemiological and Virological Characteristics of Influenza in Chongqing, China, 2011-2015.
    PLoS One. 2016;11:e0167866.
    PubMed     Text format     Abstract available


  303. SAUNDERS-HASTINGS P, Reisman J, Krewski D
    Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis.
    PLoS One. 2016;11:e0168262.
    PubMed     Text format     Abstract available


  304. WANG B, Russell ML, Moss L, Fonseca K, et al
    Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.
    PLoS One. 2016;11:e0167281.
    PubMed     Text format     Abstract available


  305. WONG C, Jiang M, You JH
    Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    PLoS One. 2016;11:e0169030.
    PubMed     Text format     Abstract available


  306. LAMBKIN-WILLIAMS R, Gelder C, Broughton R, Mallett CP, et al
    An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Inf
    PLoS One. 2016;11:e0163089.
    PubMed     Text format     Abstract available


  307. KAMIGAKI T, Chaw L, Tan AG, Tamaki R, et al
    Seasonality of Influenza and Respiratory Syncytial Viruses and the Effect of Climate Factors in Subtropical-Tropical Asia Using Influenza-Like Illness Surveillance Data, 2010 -2012.
    PLoS One. 2016;11:e0167712.
    PubMed     Text format     Abstract available


  308. RESTIVO V, Costantino C, Mammina C, Vitale F, et al
    Influenza like Illness among Medical Residents Anticipates Influenza Diffusion in General Population: Data from a National Survey among Italian Medical Residents.
    PLoS One. 2016;11:e0168546.
    PubMed     Text format     Abstract available


  309. MUKHERJEE A, Nayak MK, Dutta S, Panda S, et al
    Genetic Characterization of Circulating 2015 A(H1N1)pdm09 Influenza Viruses from Eastern India.
    PLoS One. 2016;11:e0168464.
    PubMed     Text format     Abstract available


  310. DALZIEL AE, Delean S, Heinrich S, Cassey P, et al
    Correction: Persistence of Low Pathogenic Influenza A Virus in Water: A Systematic Review and Quantitative Meta-Analysis.
    PLoS One. 2016;11:e0168789.
    PubMed     Text format     Abstract available


  311. WU Z, Sun X, Chu Y, Sun J, et al
    Coherence of Influenza Surveillance Data across Different Sources and Age Groups, Beijing, China, 2008-2015.
    PLoS One. 2016;11:e0169199.
    PubMed     Text format     Abstract available


  312. LAMB F, Ploner A, Fink K, Maeurer M, et al
    No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.
    PLoS One. 2016;11:e0154296.
    PubMed     Text format     Abstract available


  313. FLYNN JA, Durr E, Swoyer R, Cejas PJ, et al
    Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.
    PLoS One. 2016;11:e0164789.
    PubMed     Text format     Abstract available


  314. FULLEN DJ, Murray B, Mori J, Catchpole A, et al
    A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model.
    PLoS One. 2016;11:e0166113.
    PubMed     Text format     Abstract available


  315. STRANAK Z, Saliba E, Kosma P, Posfay-Barbe K, et al
    Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
    PLoS One. 2016;11:e0157446.
    PubMed     Text format     Abstract available


  316. YU Z, Liu J, Wang X, Zhu X, et al
    Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    PLoS One. 2016;11:e0155416.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: